Sign in
4

Changes in Ownership

Jasper Therapeutics, Inc. Filed Acc 0001213900-22-014564

Options or other derivatives

  • Director acquired 78,045 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nolet Chris · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-21 Grant or award : show line 1 in the form Stock Option (right to buy) +78,045 78,045 D
Loading xslF345X03/ownership.xml…